New Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel®. Read more
Interested in learning more about Myriad’s reproductive health genetic tests? Fill in your information below and we’ll send you an email with more information.
Request more information about how Myriad’s prenatal screening options can benefit your patients.
You agree to be contacted with newsletters, marketing or promotional materials and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in any email we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Policy.
Contact Information
Identify couples at risk to pass down serious, prevalent, clinically-actionable inherited conditions
Identifies fetal sex as early as six weeks into pregnancy
Identifies if a pregnancy is at an increased risk for a wide variety of chromosomal conditions as early as 10 weeks
MyRisk with RiskScore identifies inherited risk of developing 11 hereditary cancers